Trophoblastic Neoplasms: Clinical Trials

31 trials for Trophoblastic Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 7 unknown, 5 recruiting, 3 active not recruiting. 31 Phase 2, 4 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 231Completed 13, Unknown 7, Recruiting 5, Active not recruiting 3, Terminated 2, Withdrawn 1
Phase 34Unknown 4
Phase 12Completed 2

Follow Trophoblastic Neoplasms: new trials by email Literature Review of Trophoblastic Neoplasms trials Research Report on Trophoblastic Neoplasms

Trials (filtered) newest first · largest first

All 31 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers
DOMVANALIMAB + ZIMBERELIMAB, DOMVANALIMAB + ZIMBERELIMAB + FOLFOX-4 - Peritoneal Mesothelioma, Gestational Trophoblastic Tumor
Phase 2Active not recruitingHospices Civils de Lyon272025-10-012026-06-25
Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7
Toripalimab, Actinomycin-D - Gestational Trophoblastic Neoplasia
Phase 2RecruitingPeking Union Medical College Hospital172024-12-012024-12-31
Agnostic Therapy in Rare Solid Tumors
Nivolumab - Urachal Cancer, Parathyroid Carcinoma
Phase 2Active not recruitingInstituto do Cancer do Estado de São Paulo282024-07-162026-10-13
High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors
High-dose chemotherapy (TI- 2 cycles, CE- 3 cycles ) - Germ Cell Tumor
Phase 2RecruitingN.N. Petrov National Medical Research Center of Oncology252024-03-012025-08-03
A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia
Pembrolizumab - Gestational Trophoblastic Disease, Gestational Trophoblastic Neoplasia
Phase 2UnknownImperial College London202024-02-142024-04-17
Dostarlimab in Chemoresistant Gestational Trophoblastic Neoplasia
Dostarlimab - Gestational Trophoblastic Neoplasia
Phase 2WithdrawnUniversity of Miami2023-03-012023-02-28
Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia
Camrelizumab plus apatinib CohortA, Camrelizumab plus apatinib Cohort B - Gestational Trophoblastic Neoplasia
Phase 2RecruitingPeking Union Medical College Hospital702022-01-272026-11-03
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Biospecimen Collection, Carboplatin, Etoposide - Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma
Phase 2RecruitingChildren's Oncology Group1602021-07-132026-09-23
Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy
PD-1 inhibitor, bevacizumab - Gestational Trophoblastic Neoplasia
Phase 2UnknownWomen's Hospital School Of Medicine Zhejiang University202021-04-152022-06-03
Letrozole as a Prophylaxis From GTN for Complete Mole Patients
Suction evacuation, Letrozole tablets - Gestational Trophoblastic Disease
Phase 2 / Phase 3UnknownZagazig University2002020-06-012022-07-12
Phase 2 Trial for Chemo-Resistant Gestational Trophoblastic Neoplasias With Pembrolizumab (CR-GTP)
Pembrolizumab Injection [Keytruda] - Gestational Trophoblastic Neoplasia
Phase 2UnknownCHA University152020-06-012020-03-11
Camrelizumab Combined With Apatinib for Recurrent Resistant GTN
Apatinib, Camrelizumab - Gestational Trophoblastic Disease
Phase 2CompletedPeking Union Medical College Hospital202019-08-082021-07-30
Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma (GTN) Patients With Score of 5-6
MTX, MTX+ACTD - Gestational Trophoblastic Tumor, Effects of Chemotherapy
Phase 2 / Phase 3UnknownWomen's Hospital School Of Medicine Zhejiang University3002019-03-082019-03-21
Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia
Methotrexate, hysteroscopic repeat curettage - Gestational Trophoblastic Neoplasia
Phase 2RecruitingWomen's Hospital School Of Medicine Zhejiang University702019-03-012026-10-21
Rescue Regimen and High Dose Methotrexate in Management of Presistent Gestational Trophoplastic Neoplasia
rescue regimen, high dose methotrxate - Gestational Trophoblastic Disease
Phase 2 / Phase 3UnknownAssiut University1702017-10-012017-09-13
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Biospecimen Collection, Computed Tomography, Echocardiography Test - Acinar Cell Carcinoma, Adenoid Cystic Carcinoma
Phase 2Active not recruitingNational Cancer Institute (NCI)7982017-01-302026-06-17
Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)
TRC105, Bevacizumab - Gestational Trophoblastic Neoplasia, Choriocarcinoma
Phase 2TerminatedTracon Pharmaceuticals Inc.32016-03-012019-07-23
Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic Neoplasms
Total abdominal hysterectomy and methotrexate, Methotrexate plus folinic acid alone - Gestational Trophoblastic Neoplasms
Phase 2 / Phase 3UnknownMaher elesawi kamel elesawi202015-09-012017-03-22
TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma
TRC105, Bevacizumab - Choriocarcinoma
Phase 2CompletedTracon Pharmaceuticals Inc.22015-01-012019-06-11
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer
behavioral, psychological or informational intervention - Ovarian Sarcoma, Ovarian Stromal Cancer
Phase 2CompletedOhio State University Comprehensive Cancer Center1002010-10-012018-05-30

Showing 20 of 31. Sign in to see all of them.

Narrower conditions

Gestational Trophoblastic Disease (25)  ·  Carcinoma, Ovarian Epithelial (9)  ·  Breast Neoplasms (8)  ·  Neuroblastoma (8)  ·  Burkitt Lymphoma (7)  ·  Hodgkin Disease (7)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (7)  ·  Lymphoma (7)  ·  Lymphoma, B-Cell, Marginal Zone (7)  ·  Lymphoma, Follicular (7)  ·  Lymphoma, Large B-Cell, Diffuse (7)  ·  Lymphoma, Large-Cell, Immunoblastic (7)  ·  Lymphoma, Mantle-Cell (7)  ·  Lymphoma, Non-Hodgkin (7)  ·  Ovarian Neoplasms (7)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (31)  ·  Neoplasms by Histologic Type (31)  ·  Pregnancy Complications (31)  ·  Pregnancy Complications, Neoplastic (31)  ·  Urogenital Diseases (31)  ·  Neoplasms (30)  ·  Neoplasms, Germ Cell and Embryonal (30)  ·  Carcinoma (16)  ·  Neoplasms, Glandular and Epithelial (16)  ·  Neoplasms by Site (12)  ·  Female Urogenital Diseases (11)  ·  Genital Diseases (11)  ·  Genital Diseases, Female (11)  ·  Genital Neoplasms, Female (11)

Interventions

Methotrexate (3)  ·  camrelizumab (3)  ·  Alemtuzumab (2)  ·  Bevacizumab (2)  ·  Dactinomycin (2)  ·  Drug Therapy (2)  ·  Filgrastim (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Methylprednisolone (2)  ·  Nivolumab (2)  ·  Pemetrexed (2)  ·  Specimen Handling (2)  ·  apatinib (2)  ·  carotuximab (2)  ·  pembrolizumab (2)

Sponsors

Fred Hutchinson Cancer Center (4)  ·  Gynecologic Oncology Group (3)  ·  Peking Union Medical College Hospital (3)  ·  Women's Hospital School Of Medicine Zhejiang University (3)  ·  Tracon Pharmaceuticals Inc. (2)  ·  Assiut University (1)  ·  CHA University (1)  ·  Cancer Treatment Centers of America (1)  ·  Case Comprehensive Cancer Center (1)  ·  Children's Oncology Group (1)  ·  Eli Lilly and Company (1)  ·  Hospices Civils de Lyon (1)  ·  Imperial College London (1)  ·  Instituto do Cancer do Estado de São Paulo (1)  ·  Maher elesawi kamel elesawi (1)

Countries

United States (17)  ·  China (6)  ·  Canada (2)  ·  Egypt (2)  ·  Australia (1)  ·  Brazil (1)  ·  France (1)  ·  Guam (1)  ·  New Zealand (1)  ·  Norway (1)  ·  Russia (1)  ·  South Korea (1)  ·  United Kingdom (1)

Top investigators

Allan Covens, MD (2)  ·  Aleksei M Belyaev, MD,DSc,Prof. (1)  ·  Anastasios Raptis, MD (1)  ·  Camila MV Moniz, Doctor (1)  ·  Charles Theuer, MD (1)  ·  Charles Theuer, MD, PhD (1)  ·  David Hockenbery, MD (1)  ·  David Miller, MD (1)  ·  David S. Miller, MD (1)  ·  Ehsan Ghorani (1)  ·  Kristen M. Carpenter, Ph.D (1)  ·  Leona A. Holmberg, MD, PhD (1)  ·  Marilyn Huang, MD (1)  ·  Mary E. D. Flowers, MD (1)  ·  Mary Laughlin, MD (1)

Results publications

PMID 16900525, PMID 27500329, PMID 31969335, PMID 33362722, PMID 33882143, PMID 34380663, PMID 34624252, PMID 34716198, PMID 38243705, PMID 38358334, PMID 39067873, PMID 39343510, PMID 39417692, PMID 39583952, PMID 39856213, PMID 40082377, PMID 40402690, PMID 40588371, PMID 41672597, PMID 41892875, PMID 41995270, PMID 42499790

NIH funding

P30CA043703 (1), R21CA149675 (1), U10CA027469 (1), U10CA180868 (1), U10CA180886 (1), U10CA180888 (1)